Infection, Human Immunodeficiency Virus research hub

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

This study looks into switching adults with HIV, who are already successfully managing their condition with daily pills, to a new treatment of long-acting injections given every month. It aims to see if these injections work just as well and are safe.